Impetigo
📧 Sign up to get email alerts when something new happens for Impetigo.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care [NA]
A completed clinical trial assessed reducing antibiotic duration for skin and soft tissue infections in primary care using behavioral econom…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Safety and Efficacy of Mupirocin Gel in Children With Impetigo [Phase 3]
Phase 3 trial update assessing safety and efficacy of mupirocin gel in children with impetigo has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Azithromycin - Ivermectin Mass Drug Administration for Skin Disease [Phase 4]
Phase 4 trial update evaluating azithromycin-ivermectin mass drug administration for skin diseases, including scabies and yaws, with results…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo [Phase 2]
Phase 2 study assessing safety, tolerability, PK, and activity of topical ATx201 Gel in outpatients with impetigo has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL) [Phase 2]
Phase 2 trial results for TD1414 2% cream in impetigo and secondarily infected traumatic lesions report efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo [Phase 2]
Phase 2 pharmacokinetics study of 2% TD1414 cream in adults with secondarily infected traumatic lesions and impetigo has completed with resu…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo [Phase 3]
A Phase 3 trial update for SB-275833 ointment 1% for impetigo (a bacterial skin infection) is reported as completed, under GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment [Phase 3]
Phase 3 trial evaluating SB-275833 1% topical ointment versus placebo for impetigo has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo [Phase 3]
Phase 3 trial comparing ozenoxacin 1% cream with placebo in impetigo shows efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo [Phase 3]
Phase 3 trial comparing ozenoxacin 1% cream to placebo in impetigo assessed efficacy and safety, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection [Phase 4]
Phase 4 trial update on twice-daily application of Altabax for uncomplicated soft tissue infections, including impetigo and folliculitis, wi…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo [Phase 2, Phase 3]
Completed vehicle-controlled efficacy and safety study (Phase 2/3) evaluating two dose regimens of CD07223 1.5% topical gel in impetigo.
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo [Phase 2]
A Phase II trial evaluating two doses of LTX-109 for impetigo has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial [Phase 1]
A randomized, double-blind Phase 1 trial comparing 1% topical papaya leaf extract ointment with 2% mupirocin ointment for the treatment of l…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients [Phase 2]
Phase 2 study evaluating topical minocycline FXFM244 in impetigo has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: EU PV for Retapamulin-Prescribing
This document reports a completed clinical trial update on retapamulin prescribing in the EU pharmacovigilance program for impetigo.
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA [Phase 3]
Phase 3 trial comparing retapamulin to linezolid for staphylococcal skin infections including impetigo; results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Safety and Efficacy of Topical NVC-422 Gel in Impetigo [Phase 2]
Phase 2 trial evaluating the safety and efficacy of topical NVC-422 gel for impetigo has completed enrollment and reported results.
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Fucidin® Cream in the Treatment of Impetigo [Phase 4]
Phase 4 trial of Fucidin Cream for impetigo was terminated; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2008-05-02Clinical Trial Update: Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji
An NIAID-sponsored clinical trial in Fiji evaluated the prevalence of Group A Streptococcal pyoderma (impetigo) and scabies in infants. The …